Abstract:Recyclable water-soluble Pd complexes were revealed as excellent catalysts for Suzuki–Miyaura cross-coupling of challenging substrates like the antiviral nucleoside analogue 5-iodo-20-deoxyuridine.
“…Our research group has over the years developed more efficient palladium-based catalytic systems involving caged phosphine ligands such as triazaphosphaadamantane (PTA) and its derivatives (PTABS and PTAPS). 30 These ligand systems either as complexes of palladium (e.g., PTA complexes such as [Pd(Sacc) 2 (PTA) 2 ] Cat 2 or [Pd(Mal) 2 (PTA) 2 ] Cat 3 shown in Figure 1) [31][32][33] or in situ activation with a palladium precursor [PTABS with Pd(OAc) 2 ] 34 have been effective in catalyzing the modification of nucleosides (Suzuki-Miyaura, Heck alkenylation, Sonogashira coupling, aminocarbonylation) 30,35 as well as the functionalization of chloroheteroarenes (amination, etherification, and thioetherification). [36][37][38] In 2015, utilization of [Pd(Sacc) 2 (PTA) 2 ] catalytic system in catalyzing the Heck alkenylation at 1.0 mol% concentration for 5′-O-DMTr-5-iodo-2′-deoxyuridine failed…”
Section: Figure 1 Catalytic Systems Used For Cross-coupling Reactionsmentioning
confidence: 99%
“…The usefulness of PTABS as caged phosphine ligand in palladium-catalyzed cross-coupling reactions was first demonstrated by our group for a variety of applications. [32][33][34][35] Small-scale synthesis of zwitterionic ligand was accomplished by the reaction of 1,3,5-triaza-7-phosphaadamantane (PTA) with 1,4-butanesultone (Scheme 3). 34 Therefore to achieve the large-scale synthesis of PTABS, PTA would be required on a multigram scale.…”
Section: Optimization and Scale-up Of Ptabsmentioning
Ruth linker is a C5 pyrimidine modified nucleoside analogue widely utilized for the incorporation of a primary amine in a synthetic oligonucleotide. The increasing demand for non-radioactive labeling, detection of biomolecules, and assembly of COVID-19 test kits has triggered a need for scale-up of Ruth linker. Herein, an efficient protocol involving a palladium-catalyzed Heck alkenylation is described. The synthesis has been optimized with a goal of low catalyst concentration, column-free isolation, high product purity, reproducibility, and shorter reaction time. The scalability and utility of the process have been demonstrated successfully on a 100 g scale (starting material). Additionally, for scale-up of the Heck alkenylation protocol, 7-phospha-1,3,5-triaza-adamantanebutane sulfonate (PTABS) as the coordinating caged phosphine ligand was also synthesized on a multigram scale after careful optimization of the conditions.
“…Our research group has over the years developed more efficient palladium-based catalytic systems involving caged phosphine ligands such as triazaphosphaadamantane (PTA) and its derivatives (PTABS and PTAPS). 30 These ligand systems either as complexes of palladium (e.g., PTA complexes such as [Pd(Sacc) 2 (PTA) 2 ] Cat 2 or [Pd(Mal) 2 (PTA) 2 ] Cat 3 shown in Figure 1) [31][32][33] or in situ activation with a palladium precursor [PTABS with Pd(OAc) 2 ] 34 have been effective in catalyzing the modification of nucleosides (Suzuki-Miyaura, Heck alkenylation, Sonogashira coupling, aminocarbonylation) 30,35 as well as the functionalization of chloroheteroarenes (amination, etherification, and thioetherification). [36][37][38] In 2015, utilization of [Pd(Sacc) 2 (PTA) 2 ] catalytic system in catalyzing the Heck alkenylation at 1.0 mol% concentration for 5′-O-DMTr-5-iodo-2′-deoxyuridine failed…”
Section: Figure 1 Catalytic Systems Used For Cross-coupling Reactionsmentioning
confidence: 99%
“…The usefulness of PTABS as caged phosphine ligand in palladium-catalyzed cross-coupling reactions was first demonstrated by our group for a variety of applications. [32][33][34][35] Small-scale synthesis of zwitterionic ligand was accomplished by the reaction of 1,3,5-triaza-7-phosphaadamantane (PTA) with 1,4-butanesultone (Scheme 3). 34 Therefore to achieve the large-scale synthesis of PTABS, PTA would be required on a multigram scale.…”
Section: Optimization and Scale-up Of Ptabsmentioning
Ruth linker is a C5 pyrimidine modified nucleoside analogue widely utilized for the incorporation of a primary amine in a synthetic oligonucleotide. The increasing demand for non-radioactive labeling, detection of biomolecules, and assembly of COVID-19 test kits has triggered a need for scale-up of Ruth linker. Herein, an efficient protocol involving a palladium-catalyzed Heck alkenylation is described. The synthesis has been optimized with a goal of low catalyst concentration, column-free isolation, high product purity, reproducibility, and shorter reaction time. The scalability and utility of the process have been demonstrated successfully on a 100 g scale (starting material). Additionally, for scale-up of the Heck alkenylation protocol, 7-phospha-1,3,5-triaza-adamantanebutane sulfonate (PTABS) as the coordinating caged phosphine ligand was also synthesized on a multigram scale after careful optimization of the conditions.
“…This protocol describes the synthesis of the [Pd(Sacc) 2 (TPA) 2 ] IA complex from precursor [Pd(Sacc) 2 (Me 2 S) 2 ] I by treating with a neutral monodentate TPA ligand (molar ratio 1:2; Kapdi et al, 2014) as depicted in Figure 1.37.1. The intermediate complex [Pd(Sacc) 2 (Me 2 S) 2 ] I is synthesized by stirring palladium(II) acetate in dimethyl sulfide (as the solvent) at room temperature in the presence of a stoichiometric amount of saccharine (molar ratio of 1:2 for Pd:saccharin).…”
Section: Synthesis Of Water Soluble [Pd(sacc) 2 (Tpa) 2 ]mentioning
“…Although, in most cases, water in combination with organic solvents has been employed in carrying out such transformations (Western et al, 2003;Capek and Hocek, 2005;Capek et al, 2006;Hocek and Silhar, 2007;Cho and Shaughnessy, 2012). We have recently reported on a series of water-soluble palladium complexes, with preliminary catalyst activity being displayed against simple aryl halides and 2 -deoxypyrimidine nucleosides in water as a solvent (Kapdi et al, 2014). In this unit, we describe the Suzuki-Miyaura arylation of unprotected 2 -deoxypyrimidine and 2 -deoxypurine nucleosides (5-iodo-2 -deoxyuridine [1], 5-iodo-2 -deoxycytidine [4], 8-bromo-2 -deoxyguanosine [7], and 8-bromo-2 -deoxyadenosine [10]) using the water soluble [Pd(Sacc) 2 (TPA) 2 ] complex IA.…”
Transition metal‐catalyzed reactions in aqueous media are experiencing a constant increase in interest. In homogenous catalysis the use of water as a solvent offers advantages in cost, safety, the possibility of two‐phase catalysis and simplified separation strategies. In the life sciences, transition metal catalysis in aqueous systems enables the ligation or modification of biopolymers in buffer systems or even in their cellular environment. In biocatalysis, aqueous systems allow the simultaneous use of enzymes and transition metal catalysts in cascade reactions. The use of water‐soluble phosphine ligands still represents the most reliable and popular strategy for transferring metal catalysts into the aqueous phase. This review summarizes the recent advancements in this field since 2009 and describes current synthetic strategies for the preparation of hydrophilic phosphines and phosphites. In addition, recent applications of transition metal catalysis in aqueous solvents using these hydrophilic ligands are presented.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.